Evidence map›Paper›PMID 36419543›Full record

ArticleCommunications in statistics: Simulation and computation2022

Comparing the performance of statistical methods that generalize effect estimates from randomized controlled trials to much larger target populations.

Ian Schmid, Kara E Rudolph, Trang Quynh Nguyen, Hwanhee Hong, Marissa J Seamans, Benjamin Ackerman, Elizabeth A Stuart

Open access · greenAbstract read
In one paragraph

Article in Communications in statistics: Simulation and computation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ian SchmidDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Kara E RudolphDepartment of Emergency Medicine, University of California, Davis, Sacramento, California, U.S.A.
Trang Quynh NguyenDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Hwanhee HongDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Marissa J SeamansDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Benjamin AckermanDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Elizabeth A StuartDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A.
Johns Hopkins University · USUniversity of California, Davis · US

Funding

NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
Integrating data for causal inference in behavioral healthT32MH122357 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Rashelle Jean Musci, Elizabeth A. Stuart · 2020 to 2026
$1.8M
Mental Health Services and Systems Training ProgramT32MH109436 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Matthew Eisenberg, Elizabeth A. Stuart · 2017 to 2026
$1.7M
Mechanisms linking neighborhood poverty to problematic adolescent drug useR00DA042127 · NIDA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RUDOLPH, KARA ELIZABETH · 2018 to 2021
$889k
Estimating Population Effects in Mental Health Research Using Meta-AnalysisR00MH111807 · NIMH · DUKE UNIVERSITY · PI HONG, HWANHEE · 2018 to 2020
$747k
Generalizing RCT Efficacy Evidence: Application to NIDA Clinical Trials NetworkR01DA036520 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOJTABAI, RAMIN · 2014 to 2016
$723k
NIDA NIH HHS R00 DA042127NIDA NIH HHS R01 DA036520NIDA NIH HHS T32 DA007292NIMH NIH HHS R00 MH111807NIMH NIH HHS T32 MH109436NIMH NIH HHS T32 MH122357
6 · The paper itself

Abstract

Policymakers use results from randomized controlled trials to inform decisions about whether to implement treatments in target populations. Various methods - including inverse probability weighting, outcome modeling, and Targeted Maximum Likelihood Estimation - that use baseline data available in both the trial and target population have been proposed to generalize the trial treatment effect estimate to the target population. Often the target population is significantly larger than the trial sample, which can cause estimation challenges. We conduct simulations to compare the performance of these methods in this setting. We vary the size of the target population, the proportion of the target population selected into the trial, and the complexity of the true selection and outcome models. All methods performed poorly when the trial size was only 2% of the target population size or the target population included only 1,000 units. When the target population or the proportion of units selected into the trial was larger, some methods, such as outcome modeling using Bayesian Additive Regression Trees, performed well. We caution against generalizing using these existing approaches when the target population is much larger than the trial sample and advocate future research strives to improve methods for generalizing to large target populations.

Indexed as

causal inferenceexternal validitygeneralizability

Identifiers

PMID36419543
PMCPMC9678349
OpenAlexW3011809752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.